Effect of linker on the binding free energy of stapled p53/HDM2 complex

Haeri Im1, Sihyun Ham1

  • 1Department of Chemistry, The Research Institute of Natural Sciences, Sookmyung Women's University, Seoul, Korea.

Plos One
|May 1, 2020
PubMed

Insights

Stapled peptides that mimic tumor suppressor p53 show promise for cancer treatment by disrupting p53-HDM2 binding. Computational analysis reveals key contributions from both peptide residues and the hydrocarbon staple to binding affinity.

Area of Science:

  • Biochemistry
  • Computational Biology
  • Oncology

Background:

  • Inactivation of tumor suppressor p53 by HDM2 is a common defect in human cancers.
  • Stapled p53-mimicking peptides offer a strategy to disrupt p53-HDM2 binding and restore p53 function.
  • These peptides possess enhanced conformational and proteolytic stability.

Purpose of the Study:

  • To computationally model and thermodynamically characterize the stapled p53/HDM2 complex.
  • To investigate the contributions of individual amino acids and the hydrocarbon linker to binding affinity.
  • To guide the design of novel stapled peptides with improved binding affinity.

Main Methods:

  • Molecular docking simulations were employed to model the stapled p53/HDM2 complex.
  • Binding free energy analysis was performed using end-point calculations.
  • Decomposition of binding energy into group contributions identified key interacting residues and the staple linker.

Main Results:

  • Both epitope residues (F19, W23, L26) and the hydrocarbon staple of the stapled p53 significantly contribute to binding affinity.
  • The computational approach successfully characterized the thermodynamic contributions to binding.
  • Specific amino acid residues and the staple linker were identified as critical for high-affinity binding.

Conclusions:

  • Computational modeling provides valuable insights into the binding interactions of stapled p53 peptides with HDM2.
  • The hydrocarbon staple plays a crucial role in enhancing the binding affinity of p53-mimicking peptides.
  • This approach can facilitate the rational design of more effective stapled peptide anticancer agents by optimizing staple placement.

Related Concept Videos

Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.4K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

3.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.5K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.7K